Analysts have upgraded Intellia Therapeutics' revenue forecasts, predicting a 9.8% increase in sales for 2025. Losses are expected to narrow, with a positive sentiment shift. The company's growth outlook is positive, but slower compared to the industry average.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing